Meal intended for human consumption

Patent metadata

Field	Value
Publication number	US-9386792-B2
Application number	US-201214359487-A
Country	US
Kind code	B2
Filing date	Nov 28, 2012
Priority date	Nov 29, 2011
Publication date	Jul 12, 2016
Grant date	Jul 12, 2016

Abstract

This invention relates to a plurality of compositions for dietary health management and its use in the prevention or treatment of cardiovascular disease or type 2 diabetes, and also in the prevention and/or management of obesity and generally in weight management and loss. Thus a meal intended for human consumption is provided, the meal comprising: (a) 250-650 kilocalories (1045-4180 kiloJoules); (b) 10-50, preferably 20-50, more preferably 30-50 g fiber; (c) 10-50, preferably 10-30, more preferably 10-20 g protein; (d) 0 to 5, preferably less than 3 g starch; and (e) 0 to 2, preferably 0 to 1, most preferably 0 to 0.5 g lactose; (f) at least 20, preferably at least 30, most preferably at least 40 mg of any one flavonoid aglycone; and (g) at least 30, preferably at least 40, most preferably at least 50 mg of any one flavonoid glucoside; wherein the meal comprises 75-1000 mg of total flavonoid aglycone and flavonoid glucoside, wherein the meal comprises no more than 250 mg of any one flavonoid aglycone, wherein the meal comprises no more than 250 mg of any one flavonoid glucoside.

First claim

The invention claimed is:

1. A method,
wherein the method improves, in a subject in need thereof, the physiological insulin response to a meal; wherein the method comprises:
administering to the subject in need thereof at least one 650 kilocalorie meal comprising:
(i) 10-50 g fibre;
(ii) 10-50 g protein;
(iii) 0-5 g starch;
(iv) 0-2 g lactose;
(v) 24.4 mg apigenin;
(vi) 2.46 mg kaempferol;
(vii) 3.9 mg myricetin;
(viii) 6.92 mg quercetin; and
(ix) 21.9 mg cyaniding-3-glucoside;

wherein the at least one 650 kilocalorie meal is administered to the subject in need thereof repeatedly until the subjects physiological insulin response improves; and
wherein the improved physiological insulin response is evidenced by at least one of the parameters selected from the group consisting of”
(i) a decrease in peak blood insulin levels in the subject following consumption of the meal, compared to the peak blood insulin observed in the subject following consumption of a control meal, and
(ii) a decrease in the rate of decline of blood insulin levels in the subject following consumption of the meal, compared to the rate of decline of blood insulin levels observed following consumption of a control meal.

Assignees

• Conopco Inc

Inventors

• Berry Mark John
• Bligh Heather Frances Jennifer
• Fowler Mark Ian
• Hunter Karl John
• Macaulay Katrina

Classifications

• A23L33/21 Primary

  Addition of substantially indigestible substances, e.g. dietary fibres · CPC title

• A23V2002/00

  Food compositions, function of food ingredients or processes for food or foodstuffs · CPC title

• A23L33/17

  Amino acids, peptides or proteins · CPC title

• A23L33/30

  Dietetic or nutritional methods, e.g. for losing weight (A23L33/10 takes precedence) · CPC title

• A23L33/105

  Plant extracts, their artificial duplicates or their derivatives · CPC title